跳到正文

法规知识库 · EMA 集中审评

Jardiance

empagliflozin · EMEA/H/C/002677 · 已授权

获批上市许可

2014-05-22

欧委会决定日

2026-03-24

持有人 / 申请人

Boehringer Ingelheim International GmbH

终止日期字段

无

从产品到官方文件

文件记录

23

官方索引 23

EPAR / 审评

21

assessment / overview 等

产品信息

2

PI / presentations

其他

0

RMP / PIP 等

ATC:A10BK03

治疗领域:Diabetes Mellitus, Type 2;Heart Failure;Renal Insufficiency, Chronic

药理分类:Drugs used in diabetes

修订号:33 · 最新影响 PI 的程序:VR/0000333055

适应症(原文):Type 2 diabetes mellitus Jardiance is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance in addition to other medicinal products for the treatment of diabetes For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1. Heart failure Jardiance is indicated in adults for the treatment of symptomatic chronic heart failure. Chronic kidney disease Jardiance is indicated in adults for the treatment of chronic kidney disease.

关键日期时间轴

来自 EMA medicines JSON 日期字段;缺失字段不展示,不补推结论。

  1. 2026-03-24 · 欧委会决定

  2. 2014-05-22 · 获批上市许可

  3. 2014-03-20 · CHMP 意见通过

说明书、EPAR 与其他文件

仅展示 EMA 官方 document_url;本站不下载或镜像 PDF。

EPAR / 审评资料 21产品信息 2其他 0

EPAR / 审评资料

  • Jardiance : EPAR - Procedural steps taken and scientific information after authorisation

    procedural-steps-after · 2026-03-24

    打开官方文件 ↗
  • Jardiance-H-C-PSUSA-00010388-202404 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

    scientific-conclusion · 2025-06-25

    打开官方文件 ↗
  • Jardiance : EPAR - Risk Management Plan

    rmp · 2025-06-25

    打开官方文件 ↗
  • Jardiance : EPAR - Procedural steps taken and scientific information after authorisation (archive)

    procedural-steps-after · 2025-06-25

    打开官方文件 ↗
  • Jardiance-H-C-002677-II-0076- : EPAR - Assessment report - variation

    variation-report · 2024-02-07 · EMA/542987/2023

    打开官方文件 ↗
  • Jardiance : EPAR - Risk-management-plan summary

    rmp-summary · 2024-02-07

    打开官方文件 ↗
  • Jardiance : EPAR - Summary for the public

    overview · 2024-01-29 · EMA/193010/2022

    打开官方文件 ↗
  • Jardiance-H-C-002677-0074 : EPAR - Assessment report - variation

    variation-report · 2023-09-04 · EMA/CHMP/137741/2014

    打开官方文件 ↗
  • Jardiance-H-C-002677-II-0060 : EPAR - Assessment report - Variation

    variation-report · 2022-03-30 · EMA/102340/2022

    打开官方文件 ↗
  • Jardiance-H-C-PSUSA-00010388-202104 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

    scientific-conclusion · 2022-03-30 · EMA/193077/2022

    打开官方文件 ↗
  • Jardiance-H-C-002677-II-0055 : EPAR - Assessment report - Variation

    variation-report · 2021-07-23 · EMA/CHMP/275072/2021

    打开官方文件 ↗
  • Jardiance-H-C-PSUSA-00010388-201704 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

    scientific-conclusion · 2018-01-11 · EMA/19602/2018

    打开官方文件 ↗
  • Jardiance-H-C-PSUSA-00010388-201610 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

    scientific-conclusion · 2017-08-03 · EMA/493907/2017

    打开官方文件 ↗
  • Jardiance-H-A20-1442-C-2677-0023 : EPAR - Assessment Report - Article 20

    variation-report · 2017-07-05 · EMA/PRAC/637349/2016

    打开官方文件 ↗
  • Jardiance-H-A20-1442-C-2677-0023 : EPAR - Scientific Conclusion - Article 20

    scientific-conclusion · 2017-07-05

    打开官方文件 ↗
  • Jardiance-H-C-2677-II-0014 : EPAR - Assessment Report

    variation-report · 2017-03-30 · EMA/11728/2017

    打开官方文件 ↗
  • Jardiance-H-C-2677-P46-0007 : EPAR - Assessment Report

    variation-report · 2017-02-01 · EMA/70001/2017

    打开官方文件 ↗
  • Jardiance-H-C-PSUSA-00010388-201510 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisations

    scientific-conclusion · 2016-09-23 · EMA/342499/2016

    打开官方文件 ↗
  • Jardiance-H-C-2677-A20-1419-0007 : EPAR - Assessment Report - Article 20

    variation-report · 2016-05-19 · EMA/PRAC/50218/2016

    打开官方文件 ↗
  • Jardiance : EPAR - Scientific Conclusion

    scientific-conclusion · 2016-05-19

    打开官方文件 ↗
  • Jardiance : EPAR - Public assessment report

    assessment-report · 2014-06-16 · EMA/CHMP/137741/2014

    打开官方文件 ↗

产品信息

数据来自 EMA 官方 JSON;最终以 EMA / 欧委会文件为准。本页不自动给出安全或非安全结论。